Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

286
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
286
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

175
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
175
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

281
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
281
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

214
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
214
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

381
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
381
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

3.7K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sporotrichosis in patients with diabetes mellitus: A systematic review of individual participant data.

Medical mycology·2026
Same author

Non-feline transmission of sporotrichosis: a systematic review of published cases.

Revista do Instituto de Medicina Tropical de Sao Paulo·2026
Same author

Differences in epidemiological and clinical findings between localized and systemic osteoarticular infection caused by Sporothrix: A systematic review of individual participant data.

Medical mycology·2025
Same author

Changes in HIV incidence during the COVID-19 pandemic (2020-22) compared with the pre-pandemic period (2015-19) in Peru: An observational study.

PloS one·2025
Same author

Extracutaneous sporotrichosis.

Clinical microbiology reviews·2025
Same author

High Global Health Security Index is a determinant of early detection and response to monkeypox: A cross-sectional study.

PloS one·2024

Related Experiment Video

Updated: Jul 25, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.2K

Monkeypox Outbreak in Peru.

Max Carlos Ramírez-Soto1,2

  • 1Centro de Investigación en Salud Pública, Facultad de Medicina Humana, Universidad de San Martín de Porres, Lima 15011, Peru.

Medicina (Kaunas, Lithuania)
|June 28, 2023
PubMed
Summary

Monkeypox (Mpox) is a global zoonotic disease. This review examines Mpox epidemiology and prevention in Peru

Area of Science:

  • Epidemiology
  • Public Health
  • Infectious Diseases

Background:

  • Monkeypox (Mpox), caused by the Orthopoxvirus monkeypox virus (MPXV), is a zoonotic disease with historical outbreaks in Sub-Saharan Africa.
  • Global outbreaks surged from May 2022 to April 2023, affecting over 100 non-endemic countries, predominantly in the Americas and Europe.
  • Peru reported high Mpox rates, leading to its declaration as a Public Health Emergency by WHO.

Purpose of the Study:

  • To review the epidemiology and public health indicators of the 2022 Mpox outbreak in Peru.
  • To discuss prevention strategies for Mpox transmission control in Peru.
  • To inform health authorities for collaborative efforts against MPXV.

Main Methods:

  • Review of epidemiological data and public health indicators related to the 2022 Mpox outbreak in Peru.
Keywords:
Peruemergencymonkeypox outbreakpublic health

More Related Videos

Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression
10:48

Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression

Published on: May 15, 2014

11.5K
Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1
12:00

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1

Published on: April 8, 2009

10.4K

Related Experiment Videos

Last Updated: Jul 25, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.2K
Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression
10:48

Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression

Published on: May 15, 2014

11.5K
Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1
12:00

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1

Published on: April 8, 2009

10.4K
  • Analysis of MPXV transmission patterns and affected populations.
  • Examination of current vaccination strategies for high-risk groups.

    • Main Results:

    • Peru experienced the fourth-highest Mpox cases in Latin America.
    • MPXV infection disproportionately impacted men who have sex with men and HIV-infected individuals.
    • Significant challenges exist in Mpox disease control within Peru.

    Conclusions:

    • Urgent need for coordinated efforts between health authorities to control MPXV transmission in Peru.
    • Highlighting the importance of targeted vaccination strategies for high-risk populations.
    • Emphasizing the role of epidemiological surveillance in managing Mpox outbreaks.